In the journals: High-dose vitamin E may slow Alzheimer's decline
The study involved over 600 adults, almost all of them men. Their average age was 79, and all had been diagnosed with mild or moderate Alzheimer's disease. They were already taking one of the standard Alzheimer's medications, such as donepezil (Aricept).
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
